Treatment and research progress of integrated traditional Chinese medicine and western medicine for breast cancer

YANG Guo-wang

doi:10.16025/j.1674-1307.2024.01.001

您当前的位置：

首页 >

文章列表页 >

Treatment and research progress of integrated traditional Chinese medicine and western medicine for breast cancer

更新时间：2024-03-04

- Treatment and research progress of integrated traditional Chinese medicine and western medicine for breast cancer
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 1, Pages: 2-6(2024)
- 作者机构：
  
  首都医科大学附属北京中医医院，北京 100010
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.01.001
  CLC：
- Published：25 January 2024，
  
  Received：08 December 2023，
扫描看全文
杨国旺.乳腺癌中西医结合治疗研究进展［J］.北京中医药，2024，43（1）：2-6.

YANG Guo-wang.Treatment and research progress of integrated traditional Chinese medicine and western medicine for breast cancer[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(01):2-6.
杨国旺.乳腺癌中西医结合治疗研究进展［J］.北京中医药，2024，43（1）：2-6. DOI： 10.16025/j.1674-1307.2024.01.001.

YANG Guo-wang.Treatment and research progress of integrated traditional Chinese medicine and western medicine for breast cancer[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(01):2-6. DOI： 10.16025/j.1674-1307.2024.01.001.

摘要

乳腺癌（Breast cancer）是全球女性发病率和死亡率最高的恶性肿瘤。在现代医学背景下，乳腺癌的治疗选择日趋精准化与个体化，但治疗相关毒副反应与耐药是影响患者疗效提升的主要原因。中医药在乳腺癌治疗中发挥增效减毒的作用，是目前治疗乳腺癌的重要方法之一。随着现代医学进入精准医疗和价值医疗时代，如何继续发挥中西医结合治疗乳腺癌的优势是亟待解决的问题。本文分析现代乳腺癌的治疗特征，归纳中西医结合治疗乳腺癌的优势和不足，思考其未来发展方向。

Abstract

关键词

中西医结合乳腺癌述评

Keywords

references

SUNG H, FERLAY J, SIEGEL RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3):209-249.

QI J, LI M, WANG L, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data[J]. Lancet Public Health, 2023,8(12):e943-e955.

LUO H, WEI W, YE Z, et al. Liquid biopsy of methylation biomarkers in cell-free DNA[J]. Trends Mol Med, 2021,27(5):482-500.

AGOSTINETTO E, GLIGOROV J, PICCART M. Systemic therapy for early-stage breast cancer: learning from the past to build the future[J]. Nat Rev Clin Oncol, 2022,19(12):763-774.

KIRK R. Breast cancer: Fast, positive data from neosphere[J]. Nat Rev Clin Oncol, 2012,9(2):67.

VAN DER VOORT A, VAN RAMSHORST MS, VAN WERKHOVEN ED, et al. Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual ERBB2 blockade in patients with ERBB2-positive breast cancer: a secondary analysis of the TRAIN-2 randomized, phase 3 trial[J]. JAMA Oncol,2021,7(7):978-984.

KOSTOVA V, DÉSOS P, STARCK JB, et al. The chemistry behind ADCs[J]. Pharmaceuticals (Basel),2021,14(5):442.

WU C, SUN C, LIU G, et al. Effectiveness of the Sanyin Formula Plus chemotherapy on survival in women with triple-negative breast cancer: A randomized controlled trial[J]. Front Oncol, 2022,12:850155.

罗楚凡, 刘宁远, 张静,等. 蒌慈散结方防治三阴性乳腺癌复发转移的临床观察[J]. 北京中医药,2020,39(10):1022-1027.

MOK TS, YEO W, JOHNSON PJ, et al. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity[J]. Ann Oncol, 2007,18(4):768-774.

李同达, 韩丹阳, 付雪松,等. 温心炙草汤对乳腺癌阿霉素化疗相关心脏毒性的影响[J]. 中医药信息,2023,40(7):67-70,76.

薛梦婷, 杨敏, 潘娅岚,等. 基于AMSTAR2质量评价和GRADE分级的中医药防治化疗后骨髓抑制疗效系统评价/Meta分析的再评价[J]. 中国全科医学,2021,24(6):718-726.

李娟娟, 梁丽春, 孔之华. 健脾补肾法对乳腺癌术后化疗所致骨髓抑制的疗效观察[J]. 中华中医药杂志,2023,38(3):1366-1369.

BURSTEIN HJ, LACCHETTI C, GRIGGS JJ. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American society of clinical oncology clinical practice guideline update on ovarian suppression summary[J]. J Oncol Pract, 2016,12(4):390-393.

GOSS PE, INGLE JN, PRITCHARD KI, et al. Extending aromatase-inhibitor adjuvant therapy to 10 years[J]. N Engl J Med,2016,375(3):209-219.

HERSHMAN DL, UNGER JM, GREENLEE H, et al. Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial[J]. JAMA,2018,320(2):167-176.

PENG N, YU M, YANG G, et al. Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial[J]. Breast, 2018,37:18-27.

HOANG H, MOLASSIOTIS A, CHAN CW, et al. New-onset insomnia among cancer patients undergoing chemotherapy: prevalence, risk factors, and its correlation with other symptoms[J]. Sleep Breath, 2020,24(1):241-251.

ZHANG J, QIN Z, SO TH, et al. Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an assessor-participant blinded, randomized, sham-controlled trial[J]. Breast Cancer Res, 2023,25(1):49.

LAWRENCE JA, GRIFFIN L, BALCUEVA EP, et al. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy[J]. J Cancer Surviv, 2016,10(1):176-184.

TONG T, PEI C, CHEN J, et al. Efficacy of acupuncture therapy for chemotherapy-related cognitive impairment in breast cancer patients[J]. Med Sci Monit, 2018,24:2919-2927.

邓卫芳, 贾颖, 裴晓华. 逍遥丸对乳腺癌癌前病变大鼠乳腺组织CXCR4及VEGF表达的影响[J]. 中华中医药杂志,2019,34(4):1386-1390.

张咏佳,黄潘雯,张永太，等.西黄丸干预大鼠乳腺癌癌前病变的效果及机制研究[J].中国中药杂志,2023,48(13):3546-3555.

李德辉,苏伊璠,范焕芳,等.西黄丸对大鼠乳腺癌癌前病变的阻断作用及对NF-κB蛋白表达的影响[J].中国老年学杂志,2021,41(1):131-134.

史文娴, 刘晓菲, 李斐斐,等. 阳和化岩汤对乳腺癌癌前病变细胞凋亡关键因子Bcl-2、细胞色素C表达影响的机制研究[J]. 陕西中医,2020,41(6):711-714,719.

孙颖, 刘晓菲, 王晓娜,等. 阳和化岩汤对乳腺癌癌前病变细胞Fas、Caspase-3和Caspase-8表达的影响[J]. 现代中西医结合杂志,2020,29(17):1825-1829.

蓝兆, 何嘉, 陈进晓,等. 八宝丹通过AKT与ERK信号通路抑制乳腺癌4T1细胞增殖[J]. 湖南中医药大学学报,2021,41(7):1022-1030.

王宽宇,冯月男,孔祥定,等.复方三金胶囊对乳腺癌荷瘤裸鼠瘤组织细胞增殖的影响[J].吉林中医药,2019,39(1):74-77.

李琳霈, 王启芝, 曾普华,等. 疏肝健脾解毒方含药血清对MDA-MB-231细胞增殖、凋亡及细胞周期的影响[J]. 时珍国医国药,2021,32(8):1849-1851.

郑轶枫, 詹丹丹, 洪时萃,等. 四逆散调节糖酵解抑制慢性心理应激介导乳腺癌进展的作用机制研究[J]. 中医肿瘤学杂志,2022,4(5):50-59.

ZHANG J, WANG N, ZHENG Y, et al. Naringenin in Si-Ni-San formula inhibits chronic psychological stress-induced breast cancer growth and metastasis by modulating estrogen metabolism through FXR/EST pathway[J]. J Adv Res, 2023,47:189-207.

SHIM SH, SUR S, STEELE R, et al. Disrupting cholesterol esterification by bitter melon suppresses triple-negative breast cancer cell growth[J]. Mol Carcinog, 2018,57(11):1599-1607.

DE VISSER KE, JOYCE JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth[J]. Cancer Cell, 2023,41(3):374-403.

江敏, 柳慧, 吴丰华. 姜黄素干预乳腺癌细胞诱导的巨噬细胞极化效应[J]. 华中科技大学学报（医学版）,2018,47(2):131-135.

LI J, WANG S, WANG N, et al. Correction to: Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration[J]. Cell Commun Signal, 2021,19(1):89.

李斐斐,史有阳,杨小娟,等.从“卫气留之”探究仙苓莲夏方增强NK细胞活性改善HER2阳性乳腺癌曲妥珠单抗耐药的机制[J].中华中医药杂志,2023,38(5):2371-2377.

杨雯靖, 念家云, 杨国旺. 中西医结合治疗乳腺癌现状及展望[J]. 北京中医药,2020,39(10):1009-1013.

更多指标>

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Guideline for diagnosis and treatment of breast cancer with integrated traditional Chinese and western medicine

Current situation and future of TCM diagnosis and treatment of breast cancer

Diagnosis and treatment plan of integrative medicine for elderly frailty

Diagnosis and treatment plan of integrated Chinese and western medicine for children with allergic purpura and purpura nephritis

Diagnosis and treatment plan of integrated Chinese and western medicine for multiple sclerosis

Related Author

No data

Related Institution

中国医学;科学院肿瘤医院

中国中医科学院广安门医院

北京中医药大学厦门医院厦门市中医院

国家老年医学中心北京医院中医科

首都医科大学附属北京儿童医院中医科

⁰